Sound Income Strategies LLC Boosts Stake in Perrigo Company plc $PRGO
Sound Income Strategies LLC significantly increased its stake in Perrigo Company plc (NYSE:PRGO) by 58.6% in the fourth quarter, now owning 1,138,357 shares valued at $17.11 million. Despite this, analyst sentiment remains negative with a consensus "Reduce" rating and an average price target of $19.33, following Perrigo's recent earnings per share miss. The company announced a quarterly dividend of $0.29, offering an annualized yield of approximately 11.0%.
Perrigo Co. PLC stock underperforms Monday when compared to competitors
Perrigo Co. PLC (PRGO) shares fell by 2.40% on Monday, closing at $10.59, despite a positive trading session for the broader market with the S&P 500 and Dow Jones Industrial Average both rising. This marks the second consecutive day of losses for the company's stock.
Perrigo Co PLC (MEX:PRGO) Stock Price, Trades & News
This GuruFocus article provides a detailed stock analysis of Perrigo Co PLC (MEX:PRGO), a consumer health company. It covers key financial metrics, warning signs, growth and profitability ranks, dividend information, and upcoming investor events, including earnings dates and past press releases. The company primarily sells private-label consumer health goods in North America and national brands in Europe, Australia, and parts of Asia.
Can Perrigo (PRGO) Cut Jobs Yet Sustain Innovation, Expansion and Its Dividend Commitment?
Perrigo (PRGO) announced plans to cut 7% of its global workforce, focus on core businesses, and deepen retailer partnerships, while maintaining its quarterly dividend. The company aims to balance cost reductions with continued investment in innovation and geographic expansion, with 2027 projected as a key year for accelerated plans. This move seeks to protect margins amid ongoing net losses and a guided sales decline, but also heightens risk if earnings do not improve, potentially impacting reinvestment.
Can Perrigo (PRGO) Cut Jobs Yet Sustain Innovation, Expansion and Its Dividend Commitment?
Perrigo Company plc announced plans to cut 7% of its global workforce, focus on core businesses, and deepen retailer partnerships to streamline operations amidst a soft market. This strategy aims to balance cost reductions with continued investment in innovation, geographic expansion, and maintaining its US$0.29 per share quarterly dividend, with 2027 targeted as a pivotal year for accelerating these plans. Investors are looking to see how these measures will impact profitability and address the risks posed by weak demand and intense competition, as the company projects $4.6 billion in revenue and $183.6 million in earnings by 2028.
Perrigo (PRGO) EVP converts 2,070 RSUs, with 1,081 shares for tax
Perrigo Company plc EVP & CHRO Robert Willis exercised 2,070 Restricted Stock Units (RSUs) to acquire an equal number of ordinary shares. To cover tax obligations, 1,081 of these shares were withheld, resulting in Willis directly holding 48,924 ordinary shares after the transaction. This activity represents a routine compensation event and not an open-market purchase or sale.
Perrigo (PRGO) CEO nets shares after 17,834-unit RSU exercise
Perrigo Company plc (PRGO) CEO Patrick Lockwood-Taylor exercised 17,834 Restricted Stock Units (RSUs) into ordinary shares on April 2, 2026. To cover tax obligations, 9,123 shares were withheld, resulting in a direct ownership of 110,846 ordinary shares after these transactions. The reported share value for the transactions was $10.85 per share.
Perrigo (PRGO) CFO boosts holdings after 6,369-share RSU exercise
Perrigo Company plc's EVP & Chief Financial Officer, Eduardo Guarita Bezerra, exercised 6,369 Restricted Stock Units (RSUs) into ordinary shares on April 2, 2026. A portion of these shares, 1,551, was disposed of to cover tax withholding obligations. Following these transactions, Bezerra directly holds 77,760 ordinary shares in Perrigo.
Perrigo Company plc (PRGO) Sells Dermacosmetics Unit in €327M Deal
Perrigo Company plc (PRGO) has announced the sale of its dermacosmetics unit, known as HRA Pharma, to Laboratory HRA Pharma for €327 million. This strategic move aligns with Perrigo's long-term intention to focus on core consumer health businesses. The transaction is expected to close in three phases by the end of 2026.
Perrigo Company plc (PRGO) Sells Dermacosmetics Unit in €327M Deal
Perrigo Company plc (PRGO) has announced the sale of its Dermacosmetics business to an affiliate of Groupe Rocher for €327 million. The sale is part of Perrigo's ongoing portfolio optimization to focus on its consumer self-care vision, following other recent divestitures. The transaction is expected to close by the end of Q3 2020.
Perrigo (PRGO) Positioned for Growth Amid Market Challenges
Perrigo Company PLC (NYSE:PRGO) is implementing a strategic transformation to enhance financial performance despite a challenging market. The company is focusing on core businesses, strengthening retailer partnerships, pursuing innovation and geographic expansion, and executing cost reductions, including a 7% workforce cut. Perrigo anticipates improved results in the latter half of 2026 and expects 2027 to be a pivotal year for strategic acceleration while maintaining its dividend policy.
Perrigo Co. PLC stock outperforms competitors on strong trading day
Perrigo Co. PLC (PRGO) saw its stock advance 1.99% to $9.72 on Monday, outperforming the broader market. While the Dow Jones Industrial Average rose, the S&P 500 Index declined, making Perrigo's gain notable on a mixed trading day. This marked the stock's second consecutive day of increases.
Perrigo (PRGO) price target decreased by 11.61% to 16.83
This article reports on a significant change in Perrigo's (PRGO) financial outlook, specifically a decrease in its price target. The target has been lowered by 11.61%, bringing it down to $16.83. This adjustment indicates a revised assessment of the company's future stock value by financial analysts.
Perrigo Co. PLC stock outperforms competitors on strong trading day
Perrigo Co. PLC's stock advanced by 1.60% to $9.53 on Friday, outperforming the S&P 500 Index and Dow Jones Industrial Average, which both experienced declines. The company's stock closed significantly below its 52-week high, reaching $28.44 on July 25th. This performance occurred during an overall dismal trading session for the market.
Perrigo Company plc (NYSE:PRGO) Receives Average Recommendation of "Reduce" from Analysts
Perrigo Company plc (NYSE:PRGO) has received a consensus "Reduce" rating from analysts, with an average 12-month price target of $19.33. The company recently missed its quarterly EPS and issued lower-than-forecast FY-2026 guidance, while its stock has traded significantly lower from its 12-month high. Despite a high annualized dividend yield of approximately 12.2%, concerns about its negative payout ratio and fluctuating analyst ratings persist.
Perrigo Co. PLC stock underperforms Thursday when compared to competitors
Perrigo Co. PLC (PRGO) shares fell by 3.20% on Thursday, closing at $9.38. This underperformance occurred during a generally negative trading session for the stock market, as the S&P 500 Index dropped by 1.74% and the Dow Jones Industrial Average fell by 1.01%. The decline ended a three-day winning streak for Perrigo's stock.
Vanguard realigns reporting; PRGO (NYSE: PRGO) shows 0 shares at parent level
The Vanguard Group filed an amended Schedule 13G for Perrigo Co PLC (NYSE: PRGO), reporting 0 shares beneficially owned due to an internal realignment effective January 12, 2026. This realignment means certain Vanguard subsidiaries will now report ownership separately, and Vanguard itself no longer claims beneficial ownership of securities held by those subsidiaries. The filing clarifies that this is an administrative change, not a sale of shares, and future disaggregated filings may show PRGO holdings under other Vanguard entities.
Perrigo Company plc Enters Amended and Restated Credit Agreement and Creates New Financial Obligations – 8-K Filing March 2026
Perrigo Company plc has entered into a new Amended and Restated Credit Agreement dated March 20, 2026, involving multiple lenders and secured by substantially all company assets. This agreement includes significant financial covenants, leverage restrictions, and limitations on dividends, which could impact the company's capital structure, liquidity, and share price. Investors are advised to monitor future disclosures regarding compliance with these terms.
Perrigo Amends Credit Agreement, Extends Revolving Facility Maturity
Perrigo Company (PRGO) has amended its credit agreement, extending the maturity of its $1.0 billion revolving credit facility to March 20, 2031, while its $972.4 million Term Loan B due April 20, 2029 remains unchanged. This amendment refinanced Term A loans through a draw on the new revolver, eliminated the credit spread adjustment on revolver borrowings, and maintained secured, guaranteed obligations with customary covenants. The revolving facility's maturity is now linked to the remaining Term Loan B and 2030 notes, encouraging future refinancing or reduction of those balances.
EDGAR Filing Documents for 0001585364-26-000028
This SEC filing details a Form 8-K for PERRIGO Co plc (CIK: 0001585364), filed on March 23, 2026. The report covers an entry into a material definitive agreement and the creation of a direct financial obligation, with the period of report being March 20, 2026. It includes numerous exhibits, primarily graphic files and an iXBRL 8-K document, relating to a facility agreement.
Perrigo (NYSE: PRGO) extends $1.0B revolver, keeps $972.4M term loan B
Perrigo Company plc has amended and restated its senior secured credit agreement, extending its $1.0 billion revolving credit facility to March 20, 2031, while maintaining its $972.4 million term loan B facility until April 20, 2029. The company used proceeds from the new revolver to fully prepay its prior Term A loans, thereby simplifying its debt structure. The revised agreement includes new financial covenants like maximum secured net leverage and minimum cash interest coverage ratios, offering greater lender protection.
If You Invested $1,000 in Perrigo Co Plc (PRGO)
This article analyzes the historical performance of a $1,000 investment in Perrigo Co Plc (PRGO) over 1, 5, and 10-year periods, showing significant negative returns and underperformance compared to the S&P 500. It also provides a detailed overview of Perrigo Co Plc, describing it as a pure-play self-care and consumer health company focused on OTC products, with strategic initiatives including portfolio management, cost efficiency, and a dual focus on private label and branded offerings. The report includes key financial data for PRGO and compares its historical returns to similar stocks.
Perrigo Co. PLC stock underperforms Friday when compared to competitors
Perrigo Co. PLC (PRGO) stock fell 4.15% to $9.25 on Friday, marking its third consecutive day of losses. This underperformance occurred during a generally down day for the market, with the S&P 500 Index (SPX) dropping 1.51% and the Dow Jones Industrial Average (DJIA) falling 0.96%. The article highlights the stock's struggle relative to its competitors and broader market indices.
Perrigo Co. PLC stock underperforms Thursday when compared to competitors
Perrigo Co. PLC (PRGO) stock fell 2.92% to $9.65 on Thursday, underperforming the broader market as both the S&P 500 Index and Dow Jones Industrial Average also experienced declines. This marked the second consecutive day of losses for the company's shares.
Perrigo Company plc (PRGO) Reports $1.06B Q2 Sales, Advances ‘Three-S’ Strategy
Perrigo Company plc reported second-quarter sales of $1.06 billion, a slight decrease from the previous year, but highlighted growth in its Consumer Self-Care International segment. The company is advancing its "Three-S" strategy, focusing on self-care, simplification, and supply chain optimization, which is anticipated to drive future profitability and market share gains. Management expressed confidence in achieving full-year financial targets.
Perrigo Company plc (PRGO) Reports $1.06B Q2 Sales, Advances ‘Three-S’ Strategy
Perrigo Company plc (PRGO) has announced its second-quarter sales reached $1.06 billion, demonstrating continued progress in its "Three-S" strategy focused on Supply Chain, Structure, and Strategy. The company has also achieved significant milestones, including the successful completion of the U.S. launch of Opill and the full integration of its previously acquired HRA Pharma acquisition. These achievements are bolstering the company's position in the self-care market.
Perrigo Co. PLC stock underperforms Wednesday when compared to competitors
Perrigo Co. PLC (PRGO) experienced a 3.50% decline in its stock price on Wednesday, closing at $9.94. This underperformance occurred during a generally negative trading session where both the S&P 500 Index and Dow Jones Industrial Average also saw significant declines. The stock's fall ended a two-day winning streak for Perrigo.
Perrigo (NYSE: PRGO) director granted 3,024 RSUs as equity compensation
Perrigo Company director Geoffrey M. Parker was granted 3,024 Restricted Stock Units (RSUs) on March 13, 2026, as equity compensation. These RSUs, each representing a contingent right to one Perrigo ordinary share, are scheduled to vest on March 13, 2027. Following this grant, Parker's holdings include 3,024 RSUs and a significant number of ordinary shares held directly and indirectly.
Perrigo (PRGO) director Bradley Alford awarded 3,024 RSUs vesting in 2027
Perrigo Company plc director Bradley A. Alford was granted 3,024 Restricted Stock Units (RSUs) as equity compensation, with each unit representing a contingent right to receive one ordinary share. These RSUs are scheduled to vest on March 13, 2027, and are a standard compensation-related award rather than an open-market transaction. Following this grant, Alford directly holds 3,024 RSUs and 41,160.148 ordinary shares in PRGO.
Perrigo Co. PLC stock outperforms competitors on strong trading day
Perrigo Co. PLC (PRGO) experienced a significant 5.97% stock rally, closing at $10.30, outperforming its competitors and the broader market on a strong trading day. Both the S&P 500 Index and the Dow Jones Industrial Average also saw gains. This marked the stock's second consecutive day of increases for Perrigo.
Canaccord’s Susan Anderson Trims Perrigo (PRGO) Target but Notes Share Gains in Core Business
Canaccord analyst Susan Anderson has trimmed her price target for Perrigo Company plc (PRGO) to $17 from $20, while reiterating a Buy rating. The adjustment follows Perrigo's Q4 2025 and full-year performance, which saw share gains in private label store brands and its core branded business despite a soft infant nutrition segment. The company's CEO highlighted significant progress in 2025, including market share acceleration, new distribution wins, and stabilization in the store brand segment, with plans to sell its Dermacosmetics business in Q2 2026.
Canaccord’s Susan Anderson Trims Perrigo (PRGO) Target but Notes Share Gains in Core Business
Canaccord analyst Susan Anderson has trimmed the price target for Perrigo Company plc (NYSE:PRGO) from $20 to $17, while maintaining a Buy rating. This adjustment comes despite Perrigo reporting share gains in both private label and branded businesses for Q4 2025 and the full year, although the infant nutrition segment remained soft. The company's CEO noted significant progress in 2025 across its portfolio, supported by distribution gains and market share improvements, and announced plans to sell its Dermacosmetics business.
Ion Asset Management Ltd. Sells 2,057,621 Shares of Perrigo Company plc $PRGO
Ion Asset Management Ltd. significantly reduced its stake in Perrigo Company plc (NYSE:PRGO) by 53.9%, selling over 2 million shares and now holding 1.76 million shares, making PRGO its seventh-largest position. The institutional investor's remaining stake is valued at approximately $39.2 million. This move comes as Perrigo announced a quarterly dividend of $0.29 per share, yielding 12.5%, and reported Q3 EPS of $0.77, missing estimates, with FY2026 guidance set at $2.25-$2.55 EPS.
ArrowMark Colorado Holdings LLC Trims Position in Perrigo Company plc $PRGO
ArrowMark Colorado Holdings LLC significantly reduced its stake in Perrigo Company plc (NYSE:PRGO) by 41.9% in the third quarter, selling 221,000 shares. Despite this, other hedge funds increased their positions in Perrigo. The company recently announced a quarterly dividend and analysts have issued various ratings, with the consensus being "Hold."
PRGO SEC Filings - Perrigo Co Plc 10-K, 10-Q, 8-K Forms
This page provides comprehensive access to Perrigo Co Plc's SEC filings, including 10-K, 10-Q, and 8-K reports, along with insider trading information. It details key corporate events such as earnings releases, strategic divestitures, and executive compensation changes, offering AI-powered summaries for easier understanding. The platform serves as a centralized resource for investors to track Perrigo's regulatory disclosures and major company developments.
Perrigo (PRGO) down 9.7% since last earnings report: Can it rebound?
This article discusses the performance of Perrigo (PRGO) stock, which has dropped 9.7% since its last earnings report. It aims to analyze whether the stock has the potential to rebound.
Perrigo stock hits 52-week low at 9.9 USD By Investing.com
Perrigo Company PLC's stock recently hit a new 52-week low of $9.87, reflecting a 61% drop over the past year. Despite this downturn, InvestingPro analysis suggests the stock might be oversold, offering an 11.5% dividend yield and projected analyst price targets between $15 and $20. The company reported mixed Q4 2025 earnings, slightly missing EPS forecasts but exceeding revenue.
Perrigo Co. PLC stock underperforms Wednesday when compared to competitors
Perrigo Co. PLC (PRGO) stock fell 2.87% on Wednesday, closing at $9.81 amidst a general market decline where the S&P 500 and Dow Jones also experienced losses. This marked the fifth consecutive day of losses for the company's stock.
Perrigo stock hits 52-week low at 9.9 USD
Perrigo Company PLC's stock has plunged to a new 52-week low of $9.87, representing a significant 61% decline over the past year. Despite the downturn, InvestingPro analysis suggests the stock may be oversold with potential value, offering an 11.5% dividend yield and analyst price targets ranging from $15 to $20. The company recently reported mixed Q4 2025 earnings, with an EPS miss but a revenue beat, and Jefferies maintained a Hold rating amidst ongoing challenges.
Perrigo (NYSE: PRGO) EVP awarded 8,019 shares and exercises RSUs
Perrigo Company plc executive Robert Willis, EVP & CHRO, engaged in equity transactions on March 6, 2026, where he exercised 4,501 restricted stock units into ordinary shares and received a separate grant of 8,019 ordinary shares. To cover tax obligations, 6,524 shares were withheld. Following these transactions, Willis directly holds 47,935 Perrigo ordinary shares, with the reported price for these transactions being $10.72 per share.
Perrigo (PRGO) CFO reports RSU conversions, tax withholdings and new share grant
Perrigo Company plc's CFO, Eduardo Guarita Bezerra, reported multiple equity transactions including the conversion of restricted stock units (RSUs) into ordinary shares, tax-related share withholdings, and a new share grant. These transactions, detailed in a Form 4 SEC filing, occurred on March 6, 2026, and resulted in his direct ownership of 72,942 ordinary shares. The filing outlines the exercise of RSUs, the disposal of shares for tax obligations, and the award of additional ordinary shares.
Perrigo (NYSE: PRGO) CEO gains shares through RSU vesting and new award
Perrigo Company plc (NYSE: PRGO) CEO Patrick Lockwood-Taylor has reported equity activity, including the vesting of 11,727 performance-based restricted stock units and a new grant of 13,839 restricted stock units. Shares were withheld to cover tax obligations. Following these transactions, Lockwood-Taylor directly holds 102,135 ordinary shares.
Dimensional Fund Advisors LP Purchases 181,828 Shares of Perrigo Company plc $PRGO
Dimensional Fund Advisors LP increased its stake in Perrigo Company plc (NYSE:PRGO) by 2.4% in the third quarter, acquiring an additional 181,828 shares. This brings their total holdings to 7,695,238 shares, valued at $171.37 million, representing 5.59% of the company, with institutional investors owning 95.91% of the stock. Perrigo has also declared a quarterly dividend of $0.29 per share (11.2% yield) and received an average "Hold" rating from analysts with a $19.33 price target.
BW Gestao de Investimentos Ltda. Purchases 112,595 Shares of Perrigo Company plc $PRGO
BW Gestao de Investimentos Ltda. increased its stake in Perrigo Company plc (NYSE:PRGO) by 7.7% in the third quarter, now owning 1,582,119 shares worth $35,234,000. Other institutional investors also adjusted their holdings in Perrigo, with 95.91% of the stock owned by hedge funds and institutions. The company recently reported its quarterly earnings, announcing a dividend of $0.29 per share, and analysts have issued various ratings and price targets for the stock.
Why Perrigo (PRGO) Is Down 22.0% After Deepening 2025 Losses And Weaker 2026 Sales Guidance
Perrigo (PRGO) shares fell 22.0% after reporting a widened net loss of US$1,425.4 million for full-year 2025 and projecting a further 1.5%–5.5% decline in sales for 2026. Despite these negative results, the company's board maintained its quarterly dividend of US$0.29 per share. This decision signals a continued commitment to shareholder returns even as the company faces significant profitability challenges and declining revenue forecasts.
Perrigo to Present Business Strategies at UBS Global Consumer and Retail Conference on March 9, 2026
Perrigo Company plc will participate in the UBS Global Consumer and Retail Conference on March 9, 2026. The company intends to disclose its business strategies and operations at this event. The conference provides a platform for companies in the consumer goods and retail sectors to update investors and industry professionals.
Perrigo to Present at the UBS Global Consumer and Retail Conference
Perrigo Company plc announced that its President and CEO, Patrick Lockwood-Taylor, is scheduled to present at the UBS Global Consumer and Retail Conference on Wednesday, March 11th at 11:00 AM EDT. Interested parties can access the webcast on the Perrigo investor relations website. Perrigo is a leading pure-play consumer health company focused on providing high-quality health and wellness solutions.
Hear Perrigo CEO's UBS consumer conference talk via live webcast
Perrigo (NYSE: PRGO) has announced that President and CEO Patrick Lockwood-Taylor will present at the UBS Global Consumer and Retail Conference on Wednesday, March 11, 2026, at 11:00 AM EDT. A live webcast of the presentation, covering the company’s consumer health strategy and recent developments, will be accessible on Perrigo's investor website. This event follows recent company news including sales declines, a significant goodwill impairment, and a strategic review, alongside the declaration of a quarterly dividend.
Perrigo Company plc (NYSE:PRGO) Receives Average Rating of "Hold" from Analysts
Perrigo Company plc (NYSE:PRGO) has received a consensus "Hold" rating from six brokerages, with an average 12-month price target of $19.33. The company recently missed quarterly EPS estimates and reported a 2.5% year-over-year revenue decrease, setting FY2026 guidance below analyst expectations. Perrigo also declared a $0.29 quarterly dividend, resulting in a 9.2% yield.
Bahl & Gaynor Inc. Has $46.48 Million Stake in Perrigo Company plc $PRGO
Bahl & Gaynor Inc. increased its stake in Perrigo Company plc to over 2 million shares, valued at approximately $46.48 million, making up about 1.52% of the company. Despite this, Perrigo missed Q4 EPS estimates and issued weaker-than-expected FY2026 guidance, primarily due to infant formula headwinds. The company also announced a quarterly dividend and is currently rated a "Hold" by Wall Street analysts with an average price target of $19.33.
